NEW YORK (360Dx) – Point-of-care diagnostic firm Chembio Diagnostics said Tuesday it has completed its buy of RVR Diagnostics, a privately held Malaysian POC Dx firm.

The deal was originally announced in November. Chembio CEO John Sperzel said in a statement that the acquisition is a key component of the firm's plans to grow its footprint in Europe, the Middle East, Africa and the Asia-Pacific region. The New York-based company also recently hired Robert Passas to oversee that strategy.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.